Invention Grant
- Patent Title: Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells
-
Application No.: US15695392Application Date: 2017-09-05
-
Publication No.: US10233224B2Publication Date: 2019-03-19
- Inventor: Waldemar Debinski , Hetal Pandya , Denise Gibo
- Applicant: Wake Forest University Health Sciences
- Applicant Address: US NC Winston-Salem
- Assignee: WAKE FOREST UNIVERSITY HEALTH SCIENCES
- Current Assignee: WAKE FOREST UNIVERSITY HEALTH SCIENCES
- Current Assignee Address: US NC Winston-Salem
- Agency: Myers Bigel, P.A.
- Main IPC: C12N15/24
- IPC: C12N15/24 ; C07K14/54 ; C07K19/00 ; C07K14/21 ; C07K14/34 ; G01N33/50 ; G01N33/532 ; G01N33/68 ; C07K14/005 ; C07K14/195 ; A61K47/64 ; A61K38/00

Abstract:
A compound comprising, in combination: a cell surface binding ligand or internalizing factor, such as an IL-13Rα2 binding ligand; at least one effector molecule (e.g., one, two, three or more effector molecules); optionally but preferably, a cytosol localization element covalently coupled between said binding ligand and said at least one effector molecule; and a subcellular compartment localization signal element covalently coupled between said binding ligand and said at least one effector molecule (and preferably with said cytosol localization element between said binding ligand and said subcellular compartment localization signal element). Methods of using such compounds and formulations containing the same are also described.
Public/Granted literature
- US20180002394A1 MULTI-LEVEL SPECIFIC TARGETING OF CANCER CELLS Public/Granted day:2018-01-04
Information query
IPC分类: